Universe Pharmaceuticals INC

NasdaqCM:UPC Stock Report

Market Cap: US$1.0m

Universe Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 3/6

Universe Pharmaceuticals has a total shareholder equity of $26.7M and total debt of $6.5M, which brings its debt-to-equity ratio to 24.3%. Its total assets and total liabilities are $49.4M and $22.7M respectively.

Key information

24.3%

Debt to equity ratio

US$6.51m

Debt

Interest coverage ration/a
CashUS$11.39m
EquityUS$26.74m
Total liabilitiesUS$22.69m
Total assetsUS$49.43m

Recent financial health updates

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Financial Position Analysis

Short Term Liabilities: UPC's short term assets ($33.5M) exceed its short term liabilities ($20.6M).

Long Term Liabilities: UPC's short term assets ($33.5M) exceed its long term liabilities ($2.1M).


Debt to Equity History and Analysis

Debt Level: UPC has more cash than its total debt.

Reducing Debt: UPC's debt to equity ratio has increased from 23.3% to 24.3% over the past 5 years.

Debt Coverage: UPC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if UPC's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/03/31
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Universe Pharmaceuticals INC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution